Case Study: The Effects of Mesenchymal Stem Cells on Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) stands out as one of the most prevalent forms of liver malignancies, characterized by its high recurrence rates and grim mortality statistics. Ranked as the seventh most common cancer globally, it also claims the unfortunate title of being the second leading cause of cancer-related deaths worldwide. Within the spectrum of primary liver cancers, HCC dominates as the primary histological type, accounting for over 75% of all liver cancer cases.

Recent research has shed light on the pivotal role of mesenchymal stem cells (MSCs) within the tumor microenvironment (TME), where they exhibit a dual capacity of both promoting and inhibiting the onset and progression of HCC. This dichotomy presents an intriguing avenue for HCC treatment, wherein MSCs or their modified secreted exosomes could potentially serve as therapeutic agents. However, caution is warranted, as there exists a risk of MSC-induced tumor recurrence, underscoring the need for comprehensive research to fully elucidate their impact.

In terms of treatment strategies, unraveling the molecular mechanisms underlying MSC migration is imperative to enhance recruitment efficiency and optimize targeted therapy outcomes. Furthermore, exploring the interplay between MSCs and infiltrating immune cells holds promise as a novel approach in HCC treatment paradigms. Crucially, efforts to impede the malignant transformation and tumor-promoting tendencies of MSCs are paramount in harnessing their potential as an ideal therapy for HCC.

Scientists remain hopeful that leveraging the remarkable homing capabilities and anti-HCC properties of MSCs or their exosomes could pave the way for compelling treatment modalities or adjunctive therapies in the future. As research continues to advance, unlocking the full therapeutic potential of MSCs in combating HCC remains an area ripe for exploration and innovation.

‍

Source: https://onlinelibrary.wiley.com/doi/full/10.1002/cam4.4521